Team

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.

In 2013 Dr. Olle was named "Innovator of the Year" in MIT Technology Review Spain's "Innovators under 35" awards. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. During his graduate work, Dr. Olle was awarded the "la Caixa" fellowship. Dr. Olle received his B.S. in Chemical Engineering from Universitat Rovira i Virgili, in the Republic of Catalonia, his M.S. and PhD. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. He has published his work in journals including Nature and Nature Biotechnology.

Ending the War on Microbes | Bernat Olle | TEDxCambridge

dan-couto

Dan Couto

Chief Operating Officer

dan-couto

Dan Couto

Chief Operating Officer

Mr. Couto has 25 years of experience in biotechnology, biologics drug development and cGMP manufacturing, including at Merck Sharp Dohme Biologics UK (formerly Avecia Biologics) where he served as Vice President of Commercial Manufacturing Operations and was responsible for late stage and commercial manufacturing operations. In addition, Mr. Couto has held senior positions with several biotech companies including Nuvelo, Genzyme Transgenics and Advanced Biosystems and, most recently, was Senior Vice President of Manufacturing and Facilities Operations at ContraFect Corporation where he was responsible for chemistry & manufacturing controls, supply chain, quality assurance and facilities.

Mr. Couto holds multiple U.S. patents. He received his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.

debra-winslow

Debra Winslow

VP Program Management & Operations Planning

debra-winslow

Debra Winslow

VP Program Management & Operations Planning

Deb Winslow has joined Vedanta after working in the biotech industry for over 25 years in various roles from early product development through commercialization.  She received a BS in biochemistry from UNH, an MBA from Bentley University, is a Regulatory Affairs Certified (RAC) professional and a Project Management Professional (PMP).  Her roles is to set up program management and operational planning systems to ensure successful program execution across the company.

dmitri-bobilev

Dmitri Bobilev

VP, Head of Clinical Development

dmitri-bobilev

Dmitri Bobilev

VP, Head of Clinical Development

Dr. Bobilev is the VP, Head of Clinical Development at Vedanta. He is responsible for leading Vedanta’s clinical development efforts and advancing clinical testing across a range of indications, including C. difficile, cancer, and autoimmune conditions.

Prior to joining Vedanta, Dr. Bobilev served as Executive Director of Immuno-Oncology at Tesaro, where he played a key role in defining the early clinical development strategies for Tesaro’s immuno-oncology portfolio and for combination studies with niraparib (Zejula). He designed and implemented development plans for novel immune checkpoint inhibitors in multiple oncology indications. Prior to Tesaro, Dr. Bobilev served as Medical Director at Sanofi and contributed to the successful development of cabazitaxel (Jevtana).

Dr. Bobilev received his Medical Degree from Omsk Medical Institute in Russia and completed his training in Medical and Radiation Oncology at the Soroka Medical Center at Ben-Gurion University of the Negev, Israel. He held a fellowship in Oncology Drug Development at Pfizer Global Research and Development. He is board certified in medical oncology and radiation therapy.

erik-spek-ph-d-j-d

Erik Spek, Ph.D., J.D.

SVP, Head of Legal Affairs and IP

erik-spek-ph-d-j-d

Erik Spek, Ph.D., J.D.

SVP, Head of Legal Affairs and IP

Erik Spek is the head of Intellectual Property at Vedanta. Prior to his current position, Erik was Director of IP at Epizyme and worked at Boston-based IP law firm Wolf Greenfield. Erik graduated cum laude from Suffolk Law School in Boston. He earned his B.S. in Chemistry and Philosophy from Vrije Universiteit in Amsterdam and his PhD. in Biophysical Chemistry from New York University.

aaron-bushold

Aaron Bushold

QC Manager

adam-curet

Adam Curet

Laboratory Manager

adam-tomich

Adam Tomich

Sr. Research Associate, Microbiology

adrian-douglas

Adrian Douglas

Maintenance Technician

alex-buckley

Alex Buckley

Manager, Supply Chain

alexandrea-kreuser

Alexandrea Kreuser

Clinical Supply Chain Associate

alicia-szretter

Alicia Szretter

Manager, Manufacturing

amanda-prince

Amanda Prince

Scientist II, Immunology

antonio-volpini

Antonio Volpini

Principal Research Associate, Platform

cintia-felix

Cintia Felix

Scientist I

colin-heberling

Colin Heberling

Principal Research Associate

dan-clarici

Dan Clarici

Process Engineer

dave-crane

Dave Crane

Sr. Manager, Quality Assurance

dhara-desai

Dhara Desai

Clinical Trial Associate

diana-wiesnoski

Diana Wiesnoski

Principal Research Associate, Molecular Bio & Sequencing

diti-goradia

Diti Goradia

Sr. QA Associate

evan-kustubardis

Evan Kustubardis

Senior QA Compliance Specialist

gouri-vadali

Gouri Vadali

Principle Research Associate, Systems Biology

jack-kyte

Jack Kyte

Sr. Director, Human Resources

jared-hendrickson

Jared Hendrickson

Research Associate, Bioinformatics

jason-norman-ph-d

Jason Norman, Ph.D.

Director, Systems Biology

johannes-almodovar

Johannes Almodovar

Document Control & Record Management Specialist

jil-ulrich

Jil Ulrich

Associate Director, CMC Operations

kathryn-dudley

Kathryn Dudley

EA & Executive Administrator

kelsey-brown

Kelsey Brown

Clinical Research Associate

ketaki-nade

Ketaki Nade

Analytical Development

kris-ireland

Kris Ireland

Director of Manufacturing

kwang-soo-lee

Kwang Soo Lee

Scientist, Formulation

lorraine-hughes

Lorraine Hughes

Sr Director, Clinical Operations

lou-cornacchione

Lou Cornacchione

Staff Scientist I

maggie-mcguigan

Maggie McGuigan

Controller

maria-kim

Maria Kim

Clinical Research Associate

melissa-dsouza

Melissa Dsouza

Scientist II, Clinical Bioinformatics

mollie-murnane

Mollie Murnane

Sr. Research Associate, Microbiology - Platform

rajita-menon

Rajita Menon

Scientist II, Bioinformatics

robert-dorazio

Robert D’Orazio

Lead Manufacturing Associate

rohan-chengappa

Rohan Chengappa

SAP Specialist

rose-szabady-ph-d

Rose Szabady, Ph.D.

Associate Director, Immunology

rowan-pereira

Rowan Pereira

Receptionist/Office Coordinator

ryan-busha

Ryan Busha

Sr. Sample Management Manager

sean-mcgrath

Sean McGrath

Sr. Manufacturing Associate

shana-westover

Shana Westover

Clinical Research Associate

shanfu-xie

Shanfu Xie

Sr. Research Associate, Molecular Bio & Sequencing

shilpa-reddy

Shilpa Reddy

Scientist I

silvia-caballero-ph-d

Silvia Caballero, Ph.D.

Associate Director, Infectious Diseases

steve-derby

Steve Derby

Lead Manufacturing Associate

taylor-feehley

Taylor Feehley

Director, Corporate Strategy & Development

tyler-hale

Tyler Hale

Sr. QC Specialist